Free Delivery Over $100
|
|
|||
|
||||
OverviewIsomalto-oligosaccharides (IMO) with α(1→6) and α(1→4) glucosidic linkages are produced by enzymatic conversion of starch. Isomalto-oligosaccharides are partially digested in the intestine. It was the aim of this study to investigate IMO metabolism by lactobacilli and bifidobacteria and to determine the effect of IMO diet on intestinal microbiota in a rodent model and a rodent model for inflammatory bowel disease (IBD). Different strains of bifidobacteria and lactobacilli were assessed for carbohydrates metabolism in vitro. Isomalto-oligosaccharides selectively stimulated lactobacilli in rats compared to those on control or inulin diet. The potential health benefit of IMO was evaluated in a rodent model for IBD and compared to fructo-oligosaccharides (FOS) or control diet. The Lactobacillus group and bifidobacteria numbers were increased significantly in the fecal samples of rats fed IMO or FOS diet respectively. IMO and FOS diets showed a unique effect on intestinal microbiota. Inflammation was significantly decreased in the rats fed IMO or FOS diet compared to the rats fed control diet. Full Product DetailsAuthor: Ali KetabiPublisher: LAP Lambert Academic Publishing Imprint: LAP Lambert Academic Publishing Dimensions: Width: 15.20cm , Height: 0.70cm , Length: 22.90cm Weight: 0.177kg ISBN: 9783845477992ISBN 10: 3845477997 Pages: 112 Publication Date: 13 September 2011 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: In stock  We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||
